{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Morristown",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "64317",
      "recalling_firm": "Actavis Pharmaceuticals",
      "address_1": "60 Columbia Rd Bldg B",
      "address_2": "N/A",
      "postal_code": "07960-4535",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-175-2013",
      "product_description": "buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavis South Atlantic LLC Sunrise, FL 33325 Packaged by by: America Health Packaging Columbus, OH 43217",
      "product_quantity": "14,856 bottles",
      "reason_for_recall": "Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.",
      "recall_initiation_date": "20130104",
      "center_classification_date": "20130227",
      "termination_date": "20140113",
      "report_date": "20130306",
      "code_info": "Lot CB1D05A,"
    }
  ]
}